Solutions
Accelerating Stem Cells from Concept to Clinic.
Developing the next generation of stem cell therapies is slow, hard, and expensive. Pluristyx has the expertise needed to take on the most difficult parts of your stem cell process, including off-the-shelf and custom iPSCs, process and analytical development services, gene editing, and cell line development, to help convert your concept into a clinical reality.
Pluristyx, Powered by panCELLa
A novel platform for rapid, efficient and high-quality iPSC therapy development
Using over 50 years of executive experience in development and manufacturing, Pluristyx powered by panCELLa, is a full-service, product, and technology platform that expedites your path from proof of concept to commercialization. With our panCELLa platform, you can obtain GMP edited iPSC banks within 18 months- complete with all necessary quality and regulatory documentation.
Our clients have seen a 70% reduction in development timelines and ultimately lower downstream costs. panCELLa provides a single point of access for proprietary technologies with improved freedom to operate (FTO) compared to alternative solutions. panCELLa's comprehensive suite is provided by Pluristyx’s two North American sites.
Pluristyx Powered by panCELLa
A novel platform for rapid, efficient and high-quality iPSC therapy development
Using over 50 years of executive experience in development and manufacturing, Pluristyx powered by panCELLa, is a full-service, product, and technology platform that expedites your path from proof of concept to commercialization. With our panCELLa platform, you can obtain GMP edited iPSC banks within 18 months- complete with all necessary quality and regulatory documentation.
Our clients have seen a 70% reduction in development timelines and ultimately lower downstream costs. panCELLa provides a single point of access for proprietary technologies with improved freedom to operate (FTO) compared to alternative solutions. panCELLa's comprehensive suite is provided by Pluristyx’s two North American sites.
Solutions
70% reduction in development time
Proprietary technology with clear freedom to operate
Fastest path to clinic
Case Studies
Whether you are looking for proprietary cell lines and banks, manufacturing and quality consumables, gene editing technologies, or development and GMP manufacturing services, Pluristyx gives you the opportunity to engage at any step in the process.
Large-Cap Pharm
- Internal GMP capabilities
- Seeking new iPSC lines and allogeneic cell technologies
- RESULT: Commercial license executed for iPSC lines with FailSafe® & iACT Stealth Cells™
Non-Profit
- Partnering with leading technology providers
- Looking for an end-to-end partner with holistic capabilities
- RESULT: Engagement with full panCELLa Platform
Mid-size US Biotech
- Already purchased cell lines
- Seeking GMP capabilities, gene editing and process development expertise
- RESULT: GMP process designed and executed in 12 months
Large-Cap Pharm
- Internal GMP capabilities
- Seeking new iPSC lines and allogeneic cell technologies
- RESULT: Commercial license executed for iPSC lines with FailSafe® & iACT Stealth Cells™
Non-Profit
- Partnering with leading technology providers
- Looking for an end-to-end partner with holistic capabilities
- RESULT: Engagement with full panCELLa Platform
Mid-size US Biotech
- Already purchased cell lines
- Seeking GMP capabilities, gene editing and process development expertise
- RESULT: GMP process designed and executed in 12 months
Download Brochure
